Cargando…

Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients

We have previously identified UMP-CMP kinase (CMPK1) as a prognostic marker for triple negative breast cancer (TNBC) by mass spectrometry (MS). In this study we evaluated CMPK1 association to prognosis in an independent set of samples by immunohistochemistry (IHC) and assessed biological pathways as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ning Qing, De Marchi, Tommaso, Timmermans, Annemieke, Trapman-Jansen, Anita M. A. C., Foekens, Renée, Look, Maxime P., Smid, Marcel, van Deurzen, Carolien H. M., Span, Paul N., Sweep, Fred C. G. J., Brask, Julie Benedicte, Timmermans-Wielenga, Vera, Foekens, John A., Martens, John W. M., Umar, Arzu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997324/ https://www.ncbi.nlm.nih.gov/pubmed/27558661 http://dx.doi.org/10.1038/srep32027

Ejemplares similares

Ferritin Heavy Chain in Triple Negative Breast Cancer: A Favorable Prognostic Marker that Relates to a Cluster of Differentiation 8 Positive (CD8+) Effector T-cell Response
por: Liu, Ning Qing, et al.
Publicado: (2014)

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2017)

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases
por: van den Ende, Nadine S., et al.
Publicado: (2022)

Enantioselectivity of human AMP, dTMP and UMP-CMP kinases
por: Alexandre, Julie A.C., et al.
Publicado: (2007)

Cyclic CMP and cyclic UMP: new (old) second messengers
por: Seifert, Roland, et al.
Publicado: (2011)

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
por: Riaz, Muhammad, et al.
Publicado: (2012)

4‐protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome
por: de Kruijff, Ingeborg E., et al.
Publicado: (2018)

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
por: Braakman, René B. H., et al.
Publicado: (2017)

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer
por: Umar, Arzu, et al.
Publicado: (2009)

Carcinoma in situ to invasive breast cancer
por: van Deurzen, Carolien H.M., et al.
Publicado: (2015)

Loss of Y-Chromosome during Male Breast Carcinogenesis
por: Agahozo, Marie Colombe, et al.
Publicado: (2020)

UMP-CMP kinase 2 gene expression in macrophages is dependent on the IRF3-IFNAR signaling axis
por: Kim, Hera, et al.
Publicado: (2021)

Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1
por: Topalis, Dimitri, et al.
Publicado: (2016)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis
por: Weerts, Marjolein J.A., et al.
Publicado: (2016)

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
por: Hammerl, Dora, et al.
Publicado: (2021)

Global proteomic characterization of microdissected estrogen receptor positive breast tumors
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
por: Sieuwerts, Anieta M, et al.
Publicado: (2010)

Using second harmonic generation to predict patient outcome in solid tumors
por: Burke, K., et al.
Publicado: (2015)

The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer
por: Vitale, Silvia R., et al.
Publicado: (2022)

Circular RNA in Chemonaive Lymph Node Negative Colon Cancer Patients
por: van den Berg, Inge, et al.
Publicado: (2021)

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers
por: Weerts, Marjolein J. A., et al.
Publicado: (2018)

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study
por: Hsieh, Szu-Min, et al.
Publicado: (2009)

dUMP/F-dUMP Binding to Thymidylate Synthase: Human Versus Mycobacterium tuberculosis
por: Gaurav, Kumar, et al.
Publicado: (2020)

Proteomics Pipeline for Biomarker Discovery of Laser Capture Microdissected Breast Cancer Tissue
por: Liu, Ning Qing, et al.
Publicado: (2012)

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1998)

5′-CMP and 5′-UMP promote myogenic differentiation and mitochondrial biogenesis by activating myogenin and PGC-1α in a mouse myoblast C2C12 cell line
por: Nakagawara, Kosuke, et al.
Publicado: (2022)

Inhibition of CMP-sialic acid transport by endogenous 5-methyl CMP
por: Ahuja, Shivani, et al.
Publicado: (2021)

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study
por: Schrohl, Anne-Sofie, et al.
Publicado: (2009)

Co-regulated gene expression of splicing factors as drivers of cancer progression
por: Koedoot, Esmee, et al.
Publicado: (2019)

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
por: Liu, Jingjing, et al.
Publicado: (2016)

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer
por: Yu, Jack X, et al.
Publicado: (2007)

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1(st)-line tamoxifen therapy in breast cancer
por: Uhr, K., et al.
Publicado: (2018)

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
por: van der Noord, Vera E., et al.
Publicado: (2019)

The NMR studies of CMP inhibition of polysialylation
por: Lu, Bo, et al.
Publicado: (2023)

UMP kinase activity is involved in proper chloroplast development in rice
por: Chen, Fei, et al.
Publicado: (2018)

UMP Kinase Regulates Chloroplast Development and Cold Response in Rice
por: Dong, Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_otaolgum1u955h34futfrll1ga